Quince Therapeutics

QNCX

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-53.3M

EBITDA$-56.56M

EBIT$-56.74M

Pre-tax Income$-35.21M

Net Income$-56.83M

Net Cash$30.22M

Cash Equivalent$9.65M

Total Debt$14.59M

Net Debt$-15.63M

Book Value$49.06M

Net Cash Per Share2.19

Book Value Per Share1.13

Return on Equity (ROE)-188.51%

Return on Assets (ROA)-49.64%

Return on Invested Capital (ROI)-127.80%

Net Profit Marginundefined

Current Ratio6.05

Quick Ratio5.62

Long-Term Debt / Equity0.48